Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience ; volume:22 ; number:1 ; day:14 ; month:3 ; year:2022 ; pages:1-10 ; date:12.2022
BMC cancer ; 22, Heft 1 (14.3.2022), 1-10, 12.2022
- Urheber
-
Tsubokura, Misato
Adegawa, Yuko
Kojima, Minoru
Tanosaki, Ryuji
Ohtake, Ryuzaburo
Kase, Yuki
Iwashita, Nao
Kasane, Moemi
Nakabayashi, Saori
Takeuchi, Sayaka
Kato, Ken
Boku, Narikazu
Kanemitsu, Yukihide
Okusaka, Takuji
Fujimoto, Hiroyuki
Yonemori, Kan
Ishiki, Hiroto
Kawamura, Kimihiko
Satomi, Eriko
Matsushita, Hiromichi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09298-6
- URN
-
urn:nbn:de:101:1-2022060622161037922522
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsubokura, Misato
- Adegawa, Yuko
- Kojima, Minoru
- Tanosaki, Ryuji
- Ohtake, Ryuzaburo
- Kase, Yuki
- Iwashita, Nao
- Kasane, Moemi
- Nakabayashi, Saori
- Takeuchi, Sayaka
- Kato, Ken
- Boku, Narikazu
- Kanemitsu, Yukihide
- Okusaka, Takuji
- Fujimoto, Hiroyuki
- Yonemori, Kan
- Ishiki, Hiroto
- Kawamura, Kimihiko
- Satomi, Eriko
- Matsushita, Hiromichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
Peritoneal carcinomatosis and malignant ascites
Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Historia XIX. Ascites
Observatio XXIIX. Ascites
Morbi lienis. - Ascites.
Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
Sterile cerebrospinal fluid ascites presenting as high SAAG ascites: a case report
Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
Peritoneal carcinomatosis and malignant ascites
Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Historia XIX. Ascites
Observatio XXIIX. Ascites
Morbi lienis. - Ascites.
Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
Sterile cerebrospinal fluid ascites presenting as high SAAG ascites: a case report
Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
Peritoneal carcinomatosis and malignant ascites
Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Historia XIX. Ascites
Observatio XXIIX. Ascites
Morbi lienis. - Ascites.
Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report